Cargando…

Feasibility of sentinel node navigated surgery in high-risk T1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green

BACKGROUND: Minimally invasive esophagectomy with two-field lymphadenectomy is standard of care for T1b esophageal adenocarcinoma (EAC) with a high risk of lymph node metastasis. Sentinel node navigation surgery (SNNS) is a well-known concept to tailor the extent of lymphadenectomy. The aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Overwater, Anouk, Weusten, Bas L. A. M., Ruurda, Jelle P., van Hillegersberg, Richard, Bennink, Roel J., de Keizer, Bart, Meijer, Sybren L., Brosens, Lodewijk A. A., Pouw, Roos E., Bergman, Jacques J. G. H. M., van Berge Henegouwen, Mark I., Gisbertz, Suzanne S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921120/
https://www.ncbi.nlm.nih.gov/pubmed/34046715
http://dx.doi.org/10.1007/s00464-021-08551-6
_version_ 1784669268961394688
author Overwater, Anouk
Weusten, Bas L. A. M.
Ruurda, Jelle P.
van Hillegersberg, Richard
Bennink, Roel J.
de Keizer, Bart
Meijer, Sybren L.
Brosens, Lodewijk A. A.
Pouw, Roos E.
Bergman, Jacques J. G. H. M.
van Berge Henegouwen, Mark I.
Gisbertz, Suzanne S.
author_facet Overwater, Anouk
Weusten, Bas L. A. M.
Ruurda, Jelle P.
van Hillegersberg, Richard
Bennink, Roel J.
de Keizer, Bart
Meijer, Sybren L.
Brosens, Lodewijk A. A.
Pouw, Roos E.
Bergman, Jacques J. G. H. M.
van Berge Henegouwen, Mark I.
Gisbertz, Suzanne S.
author_sort Overwater, Anouk
collection PubMed
description BACKGROUND: Minimally invasive esophagectomy with two-field lymphadenectomy is standard of care for T1b esophageal adenocarcinoma (EAC) with a high risk of lymph node metastasis. Sentinel node navigation surgery (SNNS) is a well-known concept to tailor the extent of lymphadenectomy. The aim of this study was to evaluate the feasibility and safety of SNNS with a hybrid tracer (technetium-99 m/indocyanine green/nanocolloid) for patients with high-risk T1b EAC. METHODS: In this prospective, multicenter pilot study, 5 patients with high-risk T1b EAC were included. The tracer was injected endoscopically around the endoscopic resection scar the day before surgery, followed by preoperative imaging (lymphoscintigraphy/SPECT-CT). During surgery, first the SNs were localized and resected based on preoperative imaging and intraoperative gammaprobe- and fluorescence-based detection, followed by esophagectomy. Primary endpoints were the percentage of patients with detectable SNs, concordance between preoperative and intraoperative SN detection, and the additive value of indocyanine green. RESULTS: SNs could be identified and resected in all patients (median 3 SNs per patient, range 2–7). There was a high concordance between preoperative and intraoperative SN detection. In 2 patients additional peritumoral SNs were identified with fluorescence-based detection. None of the resected lymph nodes showed signs of (micro)metastases and no nodal metastases were detected in the surgical resection specimen. CONCLUSIONS: SNNS using technetium-99 m/indocyanine green/nanocolloid seems feasible and safe in patients with high-risk T1b EAC. Indocyanine green fluorescence seems to be of additive value for detection of peritumoral SNs. Whether this approach can optimize selection for esophagectomy needs to be studied in future research. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00464-021-08551-6.
format Online
Article
Text
id pubmed-8921120
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-89211202022-03-17 Feasibility of sentinel node navigated surgery in high-risk T1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green Overwater, Anouk Weusten, Bas L. A. M. Ruurda, Jelle P. van Hillegersberg, Richard Bennink, Roel J. de Keizer, Bart Meijer, Sybren L. Brosens, Lodewijk A. A. Pouw, Roos E. Bergman, Jacques J. G. H. M. van Berge Henegouwen, Mark I. Gisbertz, Suzanne S. Surg Endosc Commentary BACKGROUND: Minimally invasive esophagectomy with two-field lymphadenectomy is standard of care for T1b esophageal adenocarcinoma (EAC) with a high risk of lymph node metastasis. Sentinel node navigation surgery (SNNS) is a well-known concept to tailor the extent of lymphadenectomy. The aim of this study was to evaluate the feasibility and safety of SNNS with a hybrid tracer (technetium-99 m/indocyanine green/nanocolloid) for patients with high-risk T1b EAC. METHODS: In this prospective, multicenter pilot study, 5 patients with high-risk T1b EAC were included. The tracer was injected endoscopically around the endoscopic resection scar the day before surgery, followed by preoperative imaging (lymphoscintigraphy/SPECT-CT). During surgery, first the SNs were localized and resected based on preoperative imaging and intraoperative gammaprobe- and fluorescence-based detection, followed by esophagectomy. Primary endpoints were the percentage of patients with detectable SNs, concordance between preoperative and intraoperative SN detection, and the additive value of indocyanine green. RESULTS: SNs could be identified and resected in all patients (median 3 SNs per patient, range 2–7). There was a high concordance between preoperative and intraoperative SN detection. In 2 patients additional peritumoral SNs were identified with fluorescence-based detection. None of the resected lymph nodes showed signs of (micro)metastases and no nodal metastases were detected in the surgical resection specimen. CONCLUSIONS: SNNS using technetium-99 m/indocyanine green/nanocolloid seems feasible and safe in patients with high-risk T1b EAC. Indocyanine green fluorescence seems to be of additive value for detection of peritumoral SNs. Whether this approach can optimize selection for esophagectomy needs to be studied in future research. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00464-021-08551-6. Springer US 2021-05-27 2022 /pmc/articles/PMC8921120/ /pubmed/34046715 http://dx.doi.org/10.1007/s00464-021-08551-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Commentary
Overwater, Anouk
Weusten, Bas L. A. M.
Ruurda, Jelle P.
van Hillegersberg, Richard
Bennink, Roel J.
de Keizer, Bart
Meijer, Sybren L.
Brosens, Lodewijk A. A.
Pouw, Roos E.
Bergman, Jacques J. G. H. M.
van Berge Henegouwen, Mark I.
Gisbertz, Suzanne S.
Feasibility of sentinel node navigated surgery in high-risk T1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green
title Feasibility of sentinel node navigated surgery in high-risk T1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green
title_full Feasibility of sentinel node navigated surgery in high-risk T1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green
title_fullStr Feasibility of sentinel node navigated surgery in high-risk T1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green
title_full_unstemmed Feasibility of sentinel node navigated surgery in high-risk T1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green
title_short Feasibility of sentinel node navigated surgery in high-risk T1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green
title_sort feasibility of sentinel node navigated surgery in high-risk t1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921120/
https://www.ncbi.nlm.nih.gov/pubmed/34046715
http://dx.doi.org/10.1007/s00464-021-08551-6
work_keys_str_mv AT overwateranouk feasibilityofsentinelnodenavigatedsurgeryinhighriskt1besophagealadenocarcinomapatientsusingahybridtraceroftechnetium99mandindocyaninegreen
AT weustenbaslam feasibilityofsentinelnodenavigatedsurgeryinhighriskt1besophagealadenocarcinomapatientsusingahybridtraceroftechnetium99mandindocyaninegreen
AT ruurdajellep feasibilityofsentinelnodenavigatedsurgeryinhighriskt1besophagealadenocarcinomapatientsusingahybridtraceroftechnetium99mandindocyaninegreen
AT vanhillegersbergrichard feasibilityofsentinelnodenavigatedsurgeryinhighriskt1besophagealadenocarcinomapatientsusingahybridtraceroftechnetium99mandindocyaninegreen
AT benninkroelj feasibilityofsentinelnodenavigatedsurgeryinhighriskt1besophagealadenocarcinomapatientsusingahybridtraceroftechnetium99mandindocyaninegreen
AT dekeizerbart feasibilityofsentinelnodenavigatedsurgeryinhighriskt1besophagealadenocarcinomapatientsusingahybridtraceroftechnetium99mandindocyaninegreen
AT meijersybrenl feasibilityofsentinelnodenavigatedsurgeryinhighriskt1besophagealadenocarcinomapatientsusingahybridtraceroftechnetium99mandindocyaninegreen
AT brosenslodewijkaa feasibilityofsentinelnodenavigatedsurgeryinhighriskt1besophagealadenocarcinomapatientsusingahybridtraceroftechnetium99mandindocyaninegreen
AT pouwroose feasibilityofsentinelnodenavigatedsurgeryinhighriskt1besophagealadenocarcinomapatientsusingahybridtraceroftechnetium99mandindocyaninegreen
AT bergmanjacquesjghm feasibilityofsentinelnodenavigatedsurgeryinhighriskt1besophagealadenocarcinomapatientsusingahybridtraceroftechnetium99mandindocyaninegreen
AT vanbergehenegouwenmarki feasibilityofsentinelnodenavigatedsurgeryinhighriskt1besophagealadenocarcinomapatientsusingahybridtraceroftechnetium99mandindocyaninegreen
AT gisbertzsuzannes feasibilityofsentinelnodenavigatedsurgeryinhighriskt1besophagealadenocarcinomapatientsusingahybridtraceroftechnetium99mandindocyaninegreen